Literature DB >> 7527335

Proteolysis of insulin-like growth factor binding protein-3 during rat pregnancy: a role for matrix metalloproteinases.

J L Fowlkes1, K Suzuki, H Nagase, K M Thrailkill.   

Abstract

Insulin-like growth factor binding protein-3 (IGFBP-3) is degraded by a cation-dependent protease(s) present in the serum of late gestation rats. Proteolysis of IGFBP-3 results in an increase in IGF-I clearance and possibly in IGF bioavailability. Based on our previous findings that matrix metalloproteinases (MMPs) degrade IGFBP-3 in fibroblast conditioned media, we hypothesized that MMPs might be involved in the degradation of IGFBP-3 by rat pregnancy serum. In the present study, we demonstrate that tissue inhibitor of metalloproteinases (TIMP-1), a specific inhibitor of all MMPs, inhibited significantly the degradation of 125I-rhIGFBP-3 by both rat pregnancy serum and rat placental extracts. Purified human MMPs (principally MMP-1 and MMP-3) degraded IGFBP-3 in solution; MMP-3 produced a pattern of IGFBP-3 degradation products identical in size to the fragments produced by pregnancy serum. Furthermore, the combined addition of antihuman MMP-1 IgG and anti-human MMP-3 IgG to rat pregnancy serum blocked almost completely the degradation of 125I-rhIGFBP-3, suggesting that these two MMPs are the principal MMPs involved in IGFBP-3 degradation in rat pregnancy serum. Together, these data suggest that MMPs function as IGFBP-3-degrading proteases in the serum of late gestational pregnant rats.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7527335     DOI: 10.1210/endo.135.6.7527335

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  12 in total

Review 1.  Cellular actions of insulin-like growth factor binding proteins.

Authors:  R J Ferry; L E Katz; A Grimberg; P Cohen; S A Weinzimer
Journal:  Horm Metab Res       Date:  1999 Feb-Mar       Impact factor: 2.936

Review 2.  Genetics, chemistry, and function of the IGF/IGFBP system.

Authors:  P F Collett-Solberg; P Cohen
Journal:  Endocrine       Date:  2000-04       Impact factor: 3.633

3.  Damage control mechanisms in articular cartilage: the role of the insulin-like growth factor I axis.

Authors:  J A Martin; M B Scherb; L A Lembke; J A Buckwalter
Journal:  Iowa Orthop J       Date:  2000

Review 4.  General aspects of insulin-like growth factor binding proteins.

Authors:  K Chan; E M Spencer
Journal:  Endocrine       Date:  1997-08       Impact factor: 3.633

Review 5.  Regulation of prostate cell growth by the insulin-like growth factor binding proteins and their proteases.

Authors:  S E Nunn; T B Gibson; R Rajah; P Cohen
Journal:  Endocrine       Date:  1997-08       Impact factor: 3.633

6.  Effects of systemic and local administration of recombinant human IGF-I (rhIGF-I) on de novo bone formation in an aged mouse model.

Authors:  John L Fowlkes; Kathryn M Thrailkill; Lichu Liu; Elizabeth C Wahl; Robert C Bunn; Gael E Cockrell; Daniel S Perrien; James Aronson; Charles K Lumpkin
Journal:  J Bone Miner Res       Date:  2006-09       Impact factor: 6.741

Review 7.  Insulin-like growth factors: actions on the skeleton.

Authors:  Shoshana Yakar; Haim Werner; Clifford J Rosen
Journal:  J Mol Endocrinol       Date:  2018-04-06       Impact factor: 5.098

Review 8.  Implications of the PAPP-A-IGFBP-IGF-1 pathway in the pathogenesis and treatment of polycystic kidney disease.

Authors:  Sonu Kashyap; Julianna D Zeidler; Claudia C S Chini; Eduardo Nunes Chini
Journal:  Cell Signal       Date:  2020-06-20       Impact factor: 4.315

9.  Insulin-like growth factor binding protein (IGFBP) substrate zymography. A new tool to identify and characterize IGFBP-degrading proteinases.

Authors:  J L Fowlkes; K M Thrailkill; D M Serra; H Nagase
Journal:  Endocrine       Date:  1997-08       Impact factor: 3.633

10.  The IGF-I/IGFBP-3 system in gingival crevicular fluid and dependence on application of fixed force.

Authors:  M Toia; R Galazzo; C Maioli; R Granata; F Scarlatti
Journal:  J Endocrinol Invest       Date:  2005-12       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.